| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445635 | European Journal of Cancer | 2012 | 6 Pages |
Abstract
This indirect analysis suggests sunitinib and pazopanib have distinct toxicity profiles which may help guide patient's choice. Further comparative data from randomised trials are awaited.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Thomas Powles, Naveed Sarwar, Rob Jones, Peter Wilson, Ekaterini Boleti, Andrew Protheroe, Simon J. Crabb, Jonathan Shamash, Andrew Stockdale, Sukaina Rashid, Paul Nathan, Simon Chowdury,